Faeth Therapeutics, Inc. (FTH)
19.39
+0.59
(+3.14%)
USD |
NASDAQ |
Oct 19, 16:00
19.39
0.00 (0.00%)
After-Hours: 16:21
Faeth Therapeutics EPS Diluted (Quarterly) : -2.836 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.836 |
| March 31, 2026 | -131.45 |
| December 31, 2025 | -3.739 |
| September 30, 2025 | -3.622 |
| June 30, 2025 | -3.915 |
| March 31, 2025 | -0.2725 |
| December 31, 2024 | -6.175 |
| September 30, 2024 | -0.2884 |
| June 30, 2024 | -0.2845 |
| March 31, 2024 | -0.319 |
| December 31, 2023 | -0.2962 |
| September 30, 2023 | -0.2792 |
| June 30, 2023 | -0.3077 |
| March 31, 2023 | -0.3297 |
| Date | Value |
|---|---|
| December 31, 2022 | -0.3979 |
| September 30, 2022 | -0.4367 |
| June 30, 2022 | -0.3431 |
| March 31, 2022 | -0.4048 |
| December 31, 2021 | -0.306 |
| September 30, 2021 | -0.3166 |
| June 30, 2021 | -0.3194 |
| March 31, 2021 | -0.2606 |
| December 31, 2020 | -0.1677 |
| September 30, 2020 | -0.1755 |
| June 30, 2020 | -0.1605 |
| March 31, 2020 | -0.1568 |
| December 31, 2019 | -0.2611 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Opus Genetics, Inc. | -0.139 |
| Nuvectis Pharma, Inc. | -0.299 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -16.01M |
| Total Expenses (Quarterly) | 16.01M |
| Enterprise Value | 306.58M |
| Earnings Yield | -730.5% |
| Normalized Earnings Yield | -335.64 |